DOXFX | SSIQX | DOXFX / SSIQX | |
Total Expense Ratio | 0.52 | 0.75 | 69% |
Annual Report Gross Expense Ratio | 0.57 | 1.01 | 56% |
Fund Existence | 3 years | 11 years | - |
Gain YTD | 31.563 | 32.811 | 96% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 60.1B | 188M | 31,968% |
Annual Yield % from dividends | 1.79 | 2.96 | 60% |
Returns for 1 year | 22.47 | 28.33 | 79% |
Returns for 3 years | 73.78 | 93.35 | 79% |
Returns for 5 years | N/A | 88.49 | - |
Returns for 10 years | N/A | 96.45 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FATEX | 129.96 | 0.29 | +0.22% |
Fidelity Advisor Technology M | |||
EMFIX | 13.73 | 0.03 | +0.22% |
Ashmore Emerging Markets Equity Instl | |||
VKSAX | 19.62 | -0.06 | -0.30% |
Virtus KAR Small-Mid Cap Core A | |||
LYFCX | 14.08 | -0.08 | -0.56% |
AlphaCentric Life Sciences & Hlthcare C | |||
NQVAX | 60.13 | -0.87 | -1.43% |
Nuveen Multi Cap Value A |